Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Messina

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Pain Medicine (Malden, Mass.)|January 28, 2016
The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American CountriesAntonio Collado, Xavier Torres, Osvaldo D Messina, et al.
Rheumatology (Oxford, England)|September 20, 2013
The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliabilityXavier Torres, Antonio Collado, Emili Gómez, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority studyKenneth G Saag, Rachel B Wagman, Piet Geusens, et al.
Neurology|March 1, 2006
MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsyA Labate, P Ventura, A Gambardella, et al.
Journal of Biological Regulators and Homeostatic Agents|December 2, 2020
Periprosthetic osteolysis: a narrative reviewA Marmotti, D Messina, A Cykowska, et al.
Plant Science : an International Journal of Experimental Plant Biology|August 5, 2023
Running the numbers on plant synthetic biology solutions to global problemsKristen Van Gelder, Edmar R Oliveira-Filho, Carlos D Messina, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2019
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy TrialKenneth G Saag, Nicola Pannacciulli, Piet Geusens, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnoverO J Degrossi, M Ortiz, E B Degrossi, et al.
The Journal of Rheumatology|October 1, 1992
Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritisO D Messina, J C Barreira, J R Zanchetta, et al.
Frontiers in Plant Science|June 30, 2023
A conceptual framework for the dynamic modeling of time-resolved phenotypes for sets of genotype-environment-management combinations: a model libraryGeorge A K van Voorn, Martin P Boer, Sandra Huynh Truong, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Pain Medicine (Malden, Mass.)|January 28, 2016
The Discriminatory Ability of the Fibromyalgia Rapid Screening Tool (FiRST): An International Study in Spain and Four Latin American CountriesAntonio Collado, Xavier Torres, Osvaldo D Messina, et al.
Rheumatology (Oxford, England)|September 20, 2013
The Spanish version of the Fibromyalgia Rapid Screening Tool: translation, validity and reliabilityXavier Torres, Antonio Collado, Emili Gómez, et al.
The Lancet. Diabetes & Endocrinology|April 11, 2018
Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority studyKenneth G Saag, Rachel B Wagman, Piet Geusens, et al.
Neurology|March 1, 2006
MRI evidence of mesial temporal sclerosis in sporadic "benign" temporal lobe epilepsyA Labate, P Ventura, A Gambardella, et al.
Journal of Biological Regulators and Homeostatic Agents|December 2, 2020
Periprosthetic osteolysis: a narrative reviewA Marmotti, D Messina, A Cykowska, et al.
Plant Science : an International Journal of Experimental Plant Biology|August 5, 2023
Running the numbers on plant synthetic biology solutions to global problemsKristen Van Gelder, Edmar R Oliveira-Filho, Carlos D Messina, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 1, 2019
Denosumab Versus Risedronate in Glucocorticoid-Induced Osteoporosis: Final Results of a Twenty-Four-Month Randomized, Double-Blind, Double-Dummy TrialKenneth G Saag, Nicola Pannacciulli, Piet Geusens, et al.
European Journal of Clinical Pharmacology|January 1, 1995
Serum kinetics, bioavailability and bone scanning of 99mTc-labelled sodium olpadronate in patients with different rates of bone turnoverO J Degrossi, M Ortiz, E B Degrossi, et al.
The Journal of Rheumatology|October 1, 1992
Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritisO D Messina, J C Barreira, J R Zanchetta, et al.
Frontiers in Plant Science|June 30, 2023
A conceptual framework for the dynamic modeling of time-resolved phenotypes for sets of genotype-environment-management combinations: a model libraryGeorge A K van Voorn, Martin P Boer, Sandra Huynh Truong, et al.
Pageof 11